ClinicalTrials.gg
Active, not recruitingNCT06913829Updated Apr 6, 2025

Efficacy Of Pencil Pushup Exercise Vs Base Out Exercising Prism's In Patient With Convergence Insufficiency

An interventional study of base-out exercising prisms and pencil pushup exercises in Convergence Insufficiency, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 10 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
10 Years to 50 Years
Sex
All
01

Study summary

Convergence insufficiency (CI) is a prevalent binocular vision disorder that leads to symptoms such as eye strain, headaches, and blurred vision during near work. This study aims to evaluate and compare the efficacy of pencil pushup exercises versus base-out exercising prisms in the management of CI. A Randomized Controlled Trial (RCT) will be conducted with 28 participants, using non-probability convenience sampling from SIGHTON Optix, Lahore. Participants will be randomly assigned to either the experimental group (receiving base-out exercising prisms) or the control group (receiving pencil push up exercises). The study will assess symptom improvement using the Convergence Insufficiency Symptom Survey (CISS), near point of convergence (NPC).

Read the detailed description

The study will also evaluate quality of life (QoL) using a vision-related QoL questionnaire. The total study duration is 3 months, with a primary goal of determining the relative efficacy of these two interventions. This study is expected to provide valuable insights into effective, evidence-based management options for convergence insufficiency, ultimately improving patient outcomes and guiding clinical practice. The collected data will be analysed by using SPSS.

02

Conditions studied

  • Convergence Insufficiency
03

In context

Ocular Motility Disorders

55 studies on the registry are indexed under Ocular Motility Disorders; 19 are open to participants now.

This study's enrollment of 28 is below the median of 90 across 39 interventional studies indexed under Ocular Motility Disorders.

Browse Ocular Motility Disorders studies →

Lead sponsor

Superior University is the lead sponsor of 253 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients having CISS score more than 16 or higher for children aged \<21 and 21 or higher for adults.
  • Patients diagnosed with convergence insufficiency based on clinical tests (e.g., near point of convergence).
  • Age group: 10-50
  • Patients experiencing symptoms related to convergence insufficiency, such as eye strain, headaches, blurred vision, or double vision during near work.
  • Able to perform pencil push-up exercises correctly after demonstration.
  • No other significant ocular or neurological conditions that might affect vision or convergence.

Exclusion criteria

Exclusion Criteria:

  • Any type of strabismus.
  • Amblyopia.
  • Refractive error more than 6 diopters.
  • Patients with history of prism prescription.
  • History of strabismus surgery or refractive error surgery.
  • History of eye trauma.
  • Any systemic and neurological diseases affecting binocular vision such as diabetes, myasthenia gravis, Graves', and multiple sclerosis.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    base-out exercising prisms

    Combination Product: base-out exercising prisms

  • Active comparator
    pencil pushup exercises

    Diagnostic Test: pencil pushup exercises

Interventions

  • Combination productbase-out exercising prisms

    Participants in the experimental group will use base-out exercising prisms as their primary intervention. This involves: 1. Procedure: * Wearing customized prism glasses designed to increase the convergence demand during near tasks. * Performing near vision activities such as reading or viewing objects while wearing the prisms. 2. Schedule: * Prisms will be prescribed based on individual clinical measurements. * Participants will use the prisms during near tasks for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks. 3. Monitoring: * Initial training will be provided to ensure proper use of the prisms. * Adherence will be checked during weekly follow-up visits, where adjustments to the prism strength will be made if necessary.

  • Diagnostic testpencil pushup exercises

    Participants in the control group will perform pencil pushup exercises as their primary intervention. This involves: 1. Procedure: o Holding a pencil or similar object vertically at arm's length and focusing on a letter or small mark on it. o Gradually moving the pencil closer to the nose until the participant experiences visual blur or sees double. o Returning the pencil to the starting position and repeating the process. 2. Schedule: o Exercises will be prescribed for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks. 3. Monitoring: o Participants will receive instructions during the initial session and periodic supervision at follow-up visits to ensure proper technique and adherence. o Progress will be monitored weekly through symptom reporting and clinical measurements.

06

What researchers measure

Primary outcomes

  1. Convergence Insufficiency Symptom Survey

    For Children (\< age 21) total score = 16 or higher is suggestive of convergence insufficiency. For Adults total score = 21 or higher is suggestive of convergence insufficiency.

    Time frame: 12 Months

  2. Quality of Life Questionnaire (QOL)

    Scoring Instructions: * Each response is scored on a scale from 1 to 5, based on the patient's answer. * A higher score indicates a greater negative impact on quality of life. Interpretation: * Low Scores (10-20): Minimal impact on quality of life. * Moderate Scores (21-35): Moderate impact on daily life and well-being. * High Scores (36-50): Significant impact on daily activities and quality of life.

    Time frame: 12 Months

07

Study locations

1 site
  • SIGHTON Optix Mozang Chungi
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Jun 2025, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2025
First posted
Apr 6, 2025
StartActual
Mar 20, 2025
Primary completionEst.
Jun 20, 2025
CompletionEst.
Feb 20, 2026
Last update
Apr 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06913829
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Apr 6, 2025
Start date
Mar 20, 2025
Primary completion
Jun 20, 2025 (estimated)
Completion
Feb 20, 2026 (estimated)
Last update
Apr 6, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion